植入式心脏复律除颤器常见风险点浅析

doi:10.19803/j.1672-8629.20240243

摘要/Abstract

摘要： 目的分析植入式心脏复律除颤器（Implantable Cardioverter Defibrillator,ICD）常见风险发生特点,为临床安全用械提供参考。方法提取2015年1月1日至2024年3月15日期间,某省医疗器械不良事件监测数据库和美国食品药品监督管理局厂商和用户使用设备体验数据库中关于ICD的不良事件报告,结合国内召回信息,对其进行统计分析。结果 ICD不良事件涉及的器械故障主要为误放电、电池提前耗竭、电极导线故障等;主要伤害为二次手术、感染、心律失常等。结论临床医务人员应充分认识该产品使用风险,权衡患者风险受益比,慎重适应证选择,规范临床使用;生产企业应加强该产品上市后风险管理,认真分析风险发生可能原因,将其作为上市前风险因素识别参考,改进产品设计,增强产品性能,降低产品固有风险。

关键词: 植入式, 除颤器, 心脏, 不良事件, 风险, 误放电, 电池提前耗竭, 电极导线故障

Abstract: Objective To analyze the common risks posed by implantable cardioverter defibrillators (ICD) and provide references for clinical safety. Methods The reports about ICD-related adverse events were retrieved from the medical device adverse event monitoring system database of one province between Jan 1, 2015 and Mar 15, 2024 and from Manufacturer and User Facility Device Experience of the US Food and Drug Administration. Combined with the domestic information on recalls, these reports were statistically analyzed. Results The device failures included inadequate shock, premature discharge of batteries and depletelectrode failure. The dominating injuries involved were secondary surgeries, infections, and arrhythmia. Conclusion Clinical medical personnel should have an intimate knowledge of the impact of adverse events of the product on patients, weigh the risk-benefit ratio of patients, select indications with caution, and standardize clinical use. Manufacturers should strengthen the post-marketing risk management of the product, analyze the possible causes of risks and use them as the pre-market risk factors, improve product design, enhance product performance, and reduce the inherent risk of products.

Key words: Implantable, Defibrillator, Heart, Adverse Event, Risk, Inadequate Shock, Premature Discharge of Battery, Depletelectrode Failure

中图分类号:

沈晓华, 张龙瑛, 丘婧婷, 吴正善, 赵燕. 植入式心脏复律除颤器常见风险点浅析[J]. 中国药物警戒, 2024, 21(11): 1284-1287.

SHEN Xiaohua, ZHANG Longying, QIU Jingting, WU Zhengshan, ZHAO Yan. Common Risks from Implantable Cardioverter Defibrillators[J]. Chinese Journal of Pharmacovigilance, 2024, 21(11): 1284-1287.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://zgywjj.magtechjournal.com/CN/10.19803/j.1672-8629.20240243

https://zgywjj.magtechjournal.com/CN/Y2024/V21/I11/1284

参考文献

[1] ZEPPENFELD K, TFELT-HANSEN J, DE RIVA M.2022 ESC Guidelines for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death[J]. European Heart Journal, 2022, 43(40): 3997-4126.
[2] VAN DER LINGEN ACJ, RIJNIERSE MT, HOOGHIEMSTRA AM, et al. The Link Between Cardiac Status and Depression and Anxiety in Implantable Cardioverter Defibrillator Patients: Design and First Results of the PSYCHE-ICD Study[J]. Journal of Psychosomatic Research, 2023, 167: 111182.
[3] HEALEY JS, KRAHN AD, BASHIR J, et al.Perioperative Safety and Early Patient and Device Outcomes Among Subcutaneous Versus Transvenous Implantable Cardioverter Defibrillator Implantations: A Randomized, Multicenter Trial[J]. Annals of Internal Medicine, 2022, 175(12): 1658-1665
[4] QIAO PF, CHEN AB, LI F, et al.Pathogenesis and Treatment Progress of Electrical Storm[J]. Journal of Modern Medical and Health(现代医药卫生), 2023, 39(18): 3162-3167.
[5] DANIEL H, JAN S, DAVID H, et al.Long-Term Incidence of Inappropriate Shocks in Patients with Implantable Cardioverter Defibrillators in Clinical Practice-an Underestimated Complication[J]. Journal of Interventional Cardiac Electrophy Siology-An International Journal of Arrhythmias and Pacing, 2017, 50(3): 219-226.
[6] CALLUM K, GRAUNE C, BOWMAN E, et al.Remote Monitoring of Implantable Defibrillators is Associated with Fewer Inappropriate Shocks and Reduced Time to Medical Assessment in A Remote and Rural Area[J]. World Journal of Cardiology, 2021, 13(3): 46-54.
[7] MOUNA KB, PEGGY J, NICOLAS B, et al.Pre-Implant Predictors of Inappropriate Shocks with the Third-Generation Subcutaneous Implantable Cardioverter Defibrillator[J]. Europace, 2022, 24(12): 1952-1959.
[8] CHENG Y, WANG RX.Causes and Mechanisms of Inappropriate Discharge of Totally Subcutaneous Implantable Cardioverter Defibrillator[J]. Journal of Practical Electrocardiography(实用心电学杂志), 2023, 32(5): 324-328, 334.
[9] MARKMAN. TM, JEFFREY S, EPSTEIN. AE. A Novel Cause of Inappropriate Subcutaneous Implantable Cardioverter-defibrillator Therapies after a Generator Change[J]. HeartRhythm Case Reports, 2021, 7(8): 562-565.
[10] SHEN YJ.Research Progress on Electrical Storm Management[J]. Medical Innovation of China(中国医学创新), 2023, 20(18): 184-188.
[11] WANG FM, GONG ZH, YU J, et al.Advances in Research on the Application Effect of Remote Follow-up Placement of Implantable cardioverter defibrillator patients[J]. Journal of Cardiovascular Rehabilitation Medicine(心血管康复医学杂志), 2022, 31(3): 391-394.
[12] CDR. The Medical Device Vigilance Alerts[EB/OL]. (2016-12-21)[2024-03-10]. https://www.cdr-adr.org.cn/ylqx_1/Medical_aqjs/Medical_aqjs_jjkx/201612/t20161221_46552.html.
[13] GUO JP, WANG YT, SHAN ZL, et al.Analysis of the Causes of Premature Battery Depletion of Pulse Generator after Cardiac Resynchronization Therapy[J]. Chinese Journal of Cardiovascular Medicine(中国心血管杂志), 2015(1): 42-45.
[14] STEVEN D, ROBERTS-THOMSON KC, INADA K, et al.Long-Term Follow-up in Patients with Presumptive Brugada Syndrome Treated with Implanted Defibrillators[J]. Journal of Cardiovascular Electrophysiology, 2011, 22(10): 1115-1119.
[15] MONTGOMERY JA, SENSING JY, SAUNDERS SD, et al.Premature Battery Depletion Due to Compromised Low-Voltage Capacitor in A Family of Defibrillators[J]. Pacing and Clinical Electrophysiology: PACE, 2019, 42(7): 965-969.
[16] OZCAN C, ROTTMAN NJ, HEIST KE, et al.Unpredictable Battery Depletion of St Jude Atlas II and Atlas+II HF Implantable Cardioverter-Defibrillators[J]. Heart Rhythm, 2012, 9(5): 717-720.
[17] CDR. The Medical Device Vigilance Alerts[EB/OL].(2021-04-23)[2024-03-10]. https://www.cdr-adr.org.cn/ylqx_1/Medical_aqjs/Medical_aqjs_jjkx/202104/t20210423_48518.html.
[18] ZHANG MR. The New Material Can Extend the Life of The Implantable Battery by 50%[N]. Science and Technology Daily(科技日报), 2022-11-09(004).
[19] CUI ZY, WANG L.The Service Life of Implantable Cardioverter Defibrillator Electrodes and The Treatment of Related Problems[J]. Chinese Journal of Cardiac Pacing and Electrophysiology(中国心脏起搏与心电生理志), 2013, 27(4): 342-344.
[20] KLEEMANN T, BECKER T, DOENGES K, et al.Annual Rate of Transvenous Defibrillation Lead Defects in Implantable Cardioverter-Defibrillators over A Period of >10 Years[J]. Circulation, 2007, 115(19): 2474-2480.
[21] DOCQ C, MARQUIE C, COLPART E, et al.Corner Fracture: an Unexpected Lead Complication in Subcutaneous Implantable Cardioverter-Defibrillator[J]. Europace, 2021, 23(9): 1471.
[22] YU HB, LIANG YC, XU GQ, et al.Observation of Long-term Effect of Implan-Table Pacemaker Sensing Electrode on Defibrillation Electrode Lead Failure[J]. Shandong Medical Journal(山东医药), 2016, 56(20): 78-80.
[23] CUI LL, HUANG WJ, WU GJ, et al.Observation of Defibrillation Lead Fault of Implantable Cardioverter Defibrillator[J]. Journal of Wenzhou Medical University(温州医科大学学报), 2012, 42(3): 264-265.
[24] YING S, LI P, CHENG AJ, et al.Buried Cardioverter Defibrillator Infection of Brucella : A Case Report[J]. Chinese Journal of Multiple Organ Diseases in the Elderly(中华老年多器官疾病杂志), 2021, 20(10): 782-783.
[25] CHU SJ, WANG YL, QI X, et al.Clinical Characteristics and Prognosis of Cardio-Vascular Implantable Electronic Device Surgery Patients with Early-and Late- Onset Infection[J]. Chinese Journal of Nosocomiology(中华医院感染学志), 2022, 32(1): 71-75.
[26] SUN TH, ZHANG JH, TANG BP, et al.Study of Postoperative Anxiety with Implantable Cardioverter Defibrillator[J]. Advances in Cardiovascular Diseases(心血管病学进展), 2023, 44(12): 1069-1073.
[27] SUN GJ, WU QY, HE L.Analysis of Causes of Death in Patients with Implantable Cardioverter-Defibrillator System[J]. Chinese Journal of Arrhythmia(中华心律失常学杂志), 2013, 17(1): 18-21.
[28] DENG Y.Risk Stratification Study of Prognosis in Patients with Implantable Cardioverter Defibrillato[D]. Peking Union Medical College, 2023.
[29] SHEN CY, SONG YN, ZHAO Y, et al.Reflections on the construction of China’s medical device alert system in the new Era[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2022, 19(7): 697-701.